{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T16:24:00Z","timestamp":1788539040982,"version":"build-2803163510"},"reference-count":172,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Cell Research"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.yexcr.2026.115145","type":"journal-article","created":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T23:22:05Z","timestamp":1785799325000},"page":"115145","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["From contested target to context-aware node: A three-layer regulatory code for interpreting FTO's oncogene\u2013tumor suppressor paradox in cancer"],"prefix":"10.1016","volume":"462","author":[{"given":"Ghaleb","family":"Oriquat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sajida Hussein","family":"Ismael","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tushar B.","family":"Gajjar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.V.","family":"Jamuna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Israa Abdulhameed","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vandana","family":"Tripathi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laxmidhar","family":"Maharana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Navin Kumar","family":"Tailor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yexcr.2026.115145_bib1","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1038\/nchembio.687","article-title":"N6-methyladenosine in nuclear RNA is a major substrate of the obesity-associated FTO","volume":"7","author":"Jia","year":"2011","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.yexcr.2026.115145_bib2","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/nature11112","article-title":"Topology of the human and mouse m6A RNA methylomes revealed by m6A-seq","volume":"485","author":"Dominissini","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.yexcr.2026.115145_bib3","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1016\/j.cell.2012.05.003","article-title":"Comprehensive analysis of mRNA methylation reveals enrichment in 3' UTRs and near stop codons","volume":"149","author":"Meyer","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.yexcr.2026.115145_bib4","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/s41568-020-0253-2","article-title":"Role of RNA modifications in cancer","volume":"20","author":"Barbieri","year":"2020","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.yexcr.2026.115145_bib5","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.ccell.2020.02.004","article-title":"m(6)A modification in coding and non-coding RNAs: roles and therapeutic implications in cancer","volume":"37","author":"Huang","year":"2020","journal-title":"Cancer Cell"},{"key":"10.1016\/j.yexcr.2026.115145_bib6","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1038\/nature08921","article-title":"Crystal structure of the FTO protein reveals basis for its substrate specificity","volume":"464","author":"Han","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.yexcr.2026.115145_bib7","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/nature21022","article-title":"Reversible methylation of m(6)A(m) in the 5' cap controls mRNA stability","volume":"541","author":"Mauer","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.yexcr.2026.115145_bib8","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.molcel.2018.08.011","article-title":"Differential m(6)A, m(6)A(m), and m(1)A demethylation mediated by FTO in the cell nucleus and cytoplasm","volume":"71","author":"Wei","year":"2018","journal-title":"Mol Cell"},{"key":"10.1016\/j.yexcr.2026.115145_bib9","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.cell.2017.11.031","article-title":"R-2HG exhibits anti-tumor activity by targeting FTO\/m(6)A\/MYC\/CEBPA signaling","volume":"172","author":"Su","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.yexcr.2026.115145_bib10","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1002\/bab.2536","article-title":"FTO-mediated ZNF687 accelerates tumor growth, metastasis, and angiogenesis in colorectal cancer through the Wnt\/\u03b2-catenin pathway","volume":"71","author":"Li","year":"2024","journal-title":"Biotechnol. Appl. Biochem."},{"key":"10.1016\/j.yexcr.2026.115145_bib11","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1080\/15476286.2020.1841458","article-title":"FTO demethylates m6A modifications in HOXB13 mRNA and promotes endometrial cancer metastasis by activating the WNT signalling pathway","volume":"18","author":"Zhang","year":"2021","journal-title":"RNA Biol."},{"key":"10.1016\/j.yexcr.2026.115145_bib12","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1038\/s41388-022-02214-z","article-title":"M(6)A demethylase FTO-mediated downregulation of DACT1 mRNA stability promotes Wnt signaling to facilitate osteosarcoma progression","volume":"41","author":"Lv","year":"2022","journal-title":"Oncogene"},{"key":"10.1016\/j.yexcr.2026.115145_bib13","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1007\/s12032-024-02369-7","article-title":"FTO promotes gastric cancer progression by modulating MAP4K4 expression via demethylation in an m6A-dependent manner","volume":"41","author":"Yin","year":"2024","journal-title":"Med. Oncol."},{"key":"10.1016\/j.yexcr.2026.115145_bib14","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1038\/s42003-024-06477-y","article-title":"RNA demethylase FTO participates in malignant progression of gastric cancer by regulating SP1-AURKB-ATM pathway","volume":"7","author":"Zeng","year":"2024","journal-title":"Commun. Biol."},{"key":"10.1016\/j.yexcr.2026.115145_bib15","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1002\/bab.2631","article-title":"Regulation of hsa_circ_0112136 by m6A demethylase FTO can enhance the malignancy of gastric cancer via the regulation of the PI3K\/AKT\/mTOR pathway","volume":"71","author":"Liu","year":"2024","journal-title":"Biotechnol. Appl. Biochem."},{"key":"10.1016\/j.yexcr.2026.115145_bib16","first-page":"385","article-title":"FTO promotes hepatocellular carcinoma progression by mediating m6A modification of BUB1 and targeting TGF-\u03b2R1 to activate the TGF-\u03b2 signaling pathway","volume":"13","author":"Zhang","year":"2025","journal-title":"J. Clin. Transl. Hepatol."},{"key":"10.1016\/j.yexcr.2026.115145_bib17","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1186\/s12964-023-01343-6","article-title":"FTO facilitates cancer metastasis by modifying the m(6)A level of FAP to induce integrin\/FAK signaling in non-small cell lung cancer","volume":"21","author":"Gao","year":"2023","journal-title":"Cell Commun. Signal."},{"key":"10.1016\/j.yexcr.2026.115145_bib18","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s00432-024-05660-2","article-title":"The antagonistic effect of FTO on METTL14 promotes AKT3 m(6)A demethylation and the progression of esophageal cancer","volume":"150","author":"Wei","year":"2024","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.yexcr.2026.115145_bib19","doi-asserted-by":"crossref","DOI":"10.1080\/15592294.2023.2242688","article-title":"FTO promotes proliferation and migration of bladder cancer via enhancing stability of STAT3 mRNA in an m6A-dependent manner","volume":"18","author":"Sun","year":"2023","journal-title":"Epigenetics"},{"key":"10.1016\/j.yexcr.2026.115145_bib20","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1007\/s10238-025-01872-z","article-title":"FTO promotes the progression of triple-negative breast cancer by regulating the m6A methylation of NFKBIE","volume":"25","author":"Zhang","year":"2025","journal-title":"Clin. Exp. Med."},{"key":"10.1016\/j.yexcr.2026.115145_bib21","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1097\/MS9.0000000000004625","article-title":"FTO promotes the cervical cancer progression via regulation of FGF2 expression","volume":"88","author":"Chen","year":"2026","journal-title":"Ann. Med. Surg."},{"key":"10.1016\/j.yexcr.2026.115145_bib22","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1002\/mc.23559","article-title":"FTO promotes the progression of cervical cancer by regulating the N6-methyladenosine modification of ZEB1 and Myc","volume":"62","author":"Wang","year":"2023","journal-title":"Mol. Carcinog."},{"key":"10.1016\/j.yexcr.2026.115145_bib23","doi-asserted-by":"crossref","first-page":"3340","DOI":"10.1007\/s10620-025-09262-x","article-title":"FTO-mediated m6A demethylation of CCL2 promotes gastric cancer progression via autophagy and oxidative stress regulation","volume":"70","author":"Wang","year":"2025","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.yexcr.2026.115145_bib24","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/jgh.70170","article-title":"FTO upregulates GLG1 expression via m(6)A methylation modification to facilitate gastric cancer cell migration and invasion","volume":"41","author":"Deng","year":"2026","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.yexcr.2026.115145_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2025.145464","article-title":"FTO promotes breast cancer development via inhibiting CYP27B1\/1,25-dihydroxyvitamin D3 asis in m6A-dependent manner","volume":"319","author":"Qin","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.yexcr.2026.115145_bib26","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1002\/cac2.12075","article-title":"The FTO\/miR-181b-3p\/ARL5B signaling pathway regulates cell migration and invasion in breast cancer","volume":"40","author":"Xu","year":"2020","journal-title":"Cancer Commun."},{"key":"10.1016\/j.yexcr.2026.115145_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2020.153042","article-title":"FTO accelerates ovarian cancer cell growth by promoting proliferation, inhibiting apoptosis, and activating autophagy","volume":"216","author":"Zhao","year":"2020","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.yexcr.2026.115145_bib28","doi-asserted-by":"crossref","first-page":"2652","DOI":"10.1007\/s10528-023-10560-0","article-title":"FTO knockdown-mediated maturation of miR-383-5p inhibits malignant advancement of pancreatic cancer by targeting ITGA3","volume":"62","author":"Zhang","year":"2024","journal-title":"Biochem. Genet."},{"key":"10.1016\/j.yexcr.2026.115145_bib29","doi-asserted-by":"crossref","first-page":"3731","DOI":"10.1002\/cam4.5054","article-title":"N(6) -methyladenosine RNA demethylase FTO regulates extracellular matrix-related genes and promotes pancreatic cancer cell migration and invasion","volume":"12","author":"Wang","year":"2023","journal-title":"Cancer Med."},{"key":"10.1016\/j.yexcr.2026.115145_bib30","doi-asserted-by":"crossref","DOI":"10.4014\/jmb.2510.10039","article-title":"FTO-mediated m6A demethylation of SERPINF1 attenuates multiple myeloma progression via the Wnt\/\u03b2-Catenin pathway","volume":"36","author":"Dong","year":"2026","journal-title":"J. Microbiol. Biotechnol."},{"key":"10.1016\/j.yexcr.2026.115145_bib31","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s13046-025-03282-1","article-title":"Oncometabolite D-2HG drives tumor metastasis and protumoral macrophage polarization by targeting FTO\/m(6)A\/ANGPTL4\/integrin axis in triple-negative breast cancer","volume":"44","author":"Zhang","year":"2025","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.yexcr.2026.115145_bib35","doi-asserted-by":"crossref","first-page":"3014","DOI":"10.1038\/s41388-025-03473-2","article-title":"K88 acetylation of FTO increases its RNA m(6)A demethylation and promotes tumorigenesis","volume":"44","author":"Li","year":"2025","journal-title":"Oncogene"},{"key":"10.1016\/j.yexcr.2026.115145_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.neo.2024.101034","article-title":"LncRNA HOTAIRM1 promotes radioresistance in nasopharyngeal carcinoma by modulating FTO acetylation-dependent alternative splicing of CD44","volume":"56","author":"Mi","year":"2024","journal-title":"Neoplasia"},{"key":"10.1016\/j.yexcr.2026.115145_bib37","doi-asserted-by":"crossref","DOI":"10.1038\/s41418-026-01680-2","article-title":"USP30 senses serine\/glycine levels to regulate serine biosynthesis and colorectal tumorigenesis by deubiquitinating FTO","author":"Qiao","year":"2026","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.yexcr.2026.115145_bib38","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1186\/s13046-023-02792-0","article-title":"m6A eraser FTO impairs gemcitabine resistance in pancreatic cancer through influencing NEDD4 mRNA stability by regulating the PTEN\/PI3K\/AKT pathway","volume":"42","author":"Lin","year":"2023","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.yexcr.2026.115145_bib39","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1038\/s41419-025-08070-5","article-title":"TRIM17 promotes the progression of osteosarcoma by regulating PDK1 m6A modification-mediated AKT\/mTOR pathway activation through ubiquitination of FTO","volume":"16","author":"Liu","year":"2025","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.yexcr.2026.115145_bib40","doi-asserted-by":"crossref","first-page":"21441","DOI":"10.1073\/pnas.2000516117","article-title":"The m(6)A RNA demethylase FTO is a HIF-independent synthetic lethal partner with the VHL tumor suppressor","volume":"117","author":"Xiao","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.yexcr.2026.115145_bib41","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/j.molcel.2020.12.026","article-title":"R-2-hydroxyglutarate attenuates aerobic glycolysis in leukemia by targeting the FTO\/m(6)A\/PFKP\/LDHB axis","volume":"81","author":"Qing","year":"2021","journal-title":"Mol Cell"},{"key":"10.1016\/j.yexcr.2026.115145_bib42","article-title":"The oncometabolite R-2-hydroxyglutarate inhibits microglial activation via the FTO\/NF-\u03baB pathway","volume":"15","author":"Wang","year":"2025","journal-title":"Front. Oncol."},{"key":"10.1016\/j.yexcr.2026.115145_bib43","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1002\/cac2.70004","article-title":"Helicobacter pylori CagA elevates FTO to induce gastric cancer progression via a \"hit-and-run\" paradigm","volume":"45","author":"He","year":"2025","journal-title":"Cancer Commun."},{"key":"10.1016\/j.yexcr.2026.115145_bib44","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.1505","article-title":"FTO up-regulation induced by MYC suppresses tumour progression in epstein-barr virus-associated gastric cancer","volume":"13","author":"Xu","year":"2023","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.yexcr.2026.115145_bib45","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s40164-024-00480-z","article-title":"A novel AML1-ETO\/FTO positive feedback loop promotes leukemogenesis and Ara-C resistance via stabilizing IGFBP2 in t(8;21) acute myeloid leukemia","volume":"13","author":"Zhou","year":"2024","journal-title":"Exp. Hematol. Oncol."},{"key":"10.1016\/j.yexcr.2026.115145_bib46","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1038\/s41419-021-03739-z","article-title":"WNT\/\u03b2-catenin-suppressed FTO expression increases m(6)A of c-Myc mRNA to promote tumor cell glycolysis and tumorigenesis","volume":"12","author":"Yang","year":"2021","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.yexcr.2026.115145_bib47","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.7150\/ijbs.102431","article-title":"TTC7B triggers the PI4KA-AKT1-RXRA-FTO axis and inhibits colon cancer cell proliferation by increasing RNA methylation","volume":"21","author":"Ren","year":"2025","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.yexcr.2026.115145_bib48","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1186\/s13046-023-02847-2","article-title":"LncRNA FTO-IT1 promotes glycolysis and progression of hepatocellular carcinoma through modulating FTO-mediated N6-methyladenosine modification on GLUT1 and PKM2","volume":"42","author":"Wang","year":"2023","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.yexcr.2026.115145_bib49","first-page":"103","article-title":"The miR-27a-3p\/FTO axis modifies hypoxia-induced malignant behaviors of glioma cells","volume":"55","author":"Du","year":"2023","journal-title":"Acta Biochim. Biophys. Sin."},{"key":"10.1016\/j.yexcr.2026.115145_bib50","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1186\/s12943-022-01619-4","article-title":"CircGPR137B\/miR-4739\/FTO feedback loop suppresses tumorigenesis and metastasis of hepatocellular carcinoma","volume":"21","author":"Liu","year":"2022","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.yexcr.2026.115145_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.113273","article-title":"m(6)A demethylase FTO stabilizes LINK-A to exert oncogenic roles via MCM3-mediated cell-cycle progression and HIF-1\u03b1 activation","volume":"42","author":"Nan","year":"2023","journal-title":"Cell Rep."},{"key":"10.1016\/j.yexcr.2026.115145_bib52","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s43556-024-00172-4","article-title":"Fat mass and obesity-associated protein (FTO) mediated m(6)A modification of circFAM192A promoted gastric cancer proliferation by suppressing SLC7A5 decay","volume":"5","author":"Wu","year":"2024","journal-title":"Mol Biomed"},{"key":"10.1016\/j.yexcr.2026.115145_bib53","first-page":"1279","article-title":"FTO-stabilized lncRNA HOXC13-AS epigenetically upregulated FZD6 and activated Wnt\/\u03b2-catenin signaling to drive cervical cancer proliferation, invasion, and EMT","volume":"26","author":"Wang","year":"2021","journal-title":"J. Buon"},{"key":"10.1016\/j.yexcr.2026.115145_bib54","doi-asserted-by":"crossref","first-page":"4543","DOI":"10.1111\/cas.15072","article-title":"Long noncoding RNA just proximal to X-inactive specific transcript facilitates aerobic glycolysis and temozolomide chemoresistance by promoting stability of PDK1 mRNA in an m6A-dependent manner in glioblastoma multiforme cells","volume":"112","author":"Li","year":"2021","journal-title":"Cancer Sci."},{"key":"10.1016\/j.yexcr.2026.115145_bib93","doi-asserted-by":"crossref","DOI":"10.1002\/jcp.31296","article-title":"FTO blocks RNA translational activity via the loss of N6-methyladenosine methylation at 5' UTR regulated by RBM5 in cisplatin-resistant NSCLC","volume":"239","author":"Li","year":"2024","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.yexcr.2026.115145_bib94","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s12894-020-00612-7","article-title":"Down-regulation of FTO promotes proliferation and migration, and protects bladder cancer cells from cisplatin-induced cytotoxicity","volume":"20","author":"Wen","year":"2020","journal-title":"BMC Urol."},{"key":"10.1016\/j.yexcr.2026.115145_bib95","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s13048-024-01385-5","article-title":"FTO attenuates the cytotoxicity of cisplatin in KGN granulosa cell-like tumour cells by regulating the Hippo\/YAP1 signalling pathway","volume":"17","author":"Wang","year":"2024","journal-title":"J. Ovarian Res."},{"key":"10.1016\/j.yexcr.2026.115145_bib85","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2025.111698","article-title":"FTO triggers NLRP3\/GSDMD-dependent pyroptosis to enhance cisplatin-sensitivity in ovarian cancer","volume":"131","author":"Zhang","year":"2025","journal-title":"Cell. Signal."},{"key":"10.1016\/j.yexcr.2026.115145_bib96","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1038\/s41419-023-06244-7","article-title":"FTO-mediated LINC01134 stabilization to promote chemoresistance through miR-140-3p\/WNT5A\/WNT pathway in PDAC","volume":"14","author":"Lu","year":"2023","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.yexcr.2026.115145_bib102","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1080\/21655979.2021.1924544","article-title":"Fat mass and obesity-associated protein (FTO) mediates signal transducer and activator of transcription 3 (STAT3)-drived resistance of breast cancer to doxorubicin","volume":"12","author":"Wang","year":"2021","journal-title":"Bioengineered"},{"key":"10.1016\/j.yexcr.2026.115145_bib103","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1002\/kjm2.12728","article-title":"FTO-mediated epigenetic upregulation of LINC01559 confers cell resistance to docetaxel in breast carcinoma by suppressing miR-1343-3p","volume":"39","author":"Lin","year":"2023","journal-title":"Kaohsiung J. Med. Sci."},{"key":"10.1016\/j.yexcr.2026.115145_bib104","doi-asserted-by":"crossref","DOI":"10.1016\/j.dmpk.2026.101519","article-title":"N(6)-methyladenosine modification of MRP7 mRNA modulates its expression and paclitaxel sensitivity in lung cancer-derived A549 cells","volume":"68","author":"Inamoto","year":"2026","journal-title":"Drug Metabol. Pharmacokinet."},{"key":"10.1016\/j.yexcr.2026.115145_bib105","doi-asserted-by":"crossref","DOI":"10.1016\/j.pupt.2024.102317","article-title":"FTO promotes gefitinib-resistance by enhancing PELI3 expression and autophagy in non-small cell lung cancer","volume":"87","author":"He","year":"2024","journal-title":"Pulm. Pharmacol. Ther."},{"key":"10.1016\/j.yexcr.2026.115145_bib106","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines13071653","article-title":"The role of fat mass and obesity-associated (FTO) gene in non-small cell lung cancer tumorigenicity and EGFR tyrosine kinase inhibitor resistance","volume":"13","author":"Rastogi","year":"2025","journal-title":"Biomedicines"},{"key":"10.1016\/j.yexcr.2026.115145_bib107","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1186\/s12885-024-13036-5","article-title":"FTO\/m6A mediates miR-138-5p maturation and regulates gefitinib resistance of lung adenocarcinoma cells by miR-138-5p\/LCN2 axis","volume":"24","author":"Ding","year":"2024","journal-title":"BMC Cancer"},{"key":"10.1016\/j.yexcr.2026.115145_bib108","doi-asserted-by":"crossref","DOI":"10.1002\/mog2.70047","article-title":"Decreased M6A modification promotes progression of gastrointestinal stromal tumor and KIT\u2010Derived imatinib resistance through FTO\u2010Regulated axis","volume":"4","author":"Li","year":"2025","journal-title":"MedComm\u2013Oncology"},{"key":"10.1016\/j.yexcr.2026.115145_bib109","doi-asserted-by":"crossref","DOI":"10.3390\/biom14080932","article-title":"The RNA demethylases ALKBH5 and FTO regulate the translation of ATF4 mRNA in sorafenib-treated Hepatocarcinoma cells","volume":"14","author":"Adjibade","year":"2024","journal-title":"Biomolecules"},{"key":"10.1016\/j.yexcr.2026.115145_bib97","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2025.103647","article-title":"FTO facilitates colorectal cancer chemoresistance via regulation of NUPR1-dependent iron homeostasis","volume":"83","author":"Xu","year":"2025","journal-title":"Redox Biol."},{"key":"10.1016\/j.yexcr.2026.115145_bib98","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.ymthe.2022.10.012","article-title":"N6-methyladenosine demethylase FTO enhances chemo-resistance in colorectal cancer through SIVA1-mediated apoptosis","volume":"31","author":"Lin","year":"2023","journal-title":"Mol. Ther."},{"key":"10.1016\/j.yexcr.2026.115145_bib67","article-title":"FTO promotes colorectal cancer progression and chemotherapy resistance via demethylating G6PD\/PARP1","volume":"12","author":"Wang","year":"2022","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.yexcr.2026.115145_bib99","doi-asserted-by":"crossref","first-page":"5717","DOI":"10.1158\/1538-7445.AM2022-5717","article-title":"Novel evidence for FTO as an oncogenic player and mediator of chemoresistance in colorectal cancer","volume":"82","author":"Garg","year":"2022","journal-title":"Cancer Res."},{"key":"10.1016\/j.yexcr.2026.115145_bib69","doi-asserted-by":"crossref","first-page":"4802","DOI":"10.7150\/thno.73746","article-title":"N(6)-methyladenosine-mediated LDHA induction potentiates chemoresistance of colorectal cancer cells through metabolic reprogramming","volume":"12","author":"Zhang","year":"2022","journal-title":"Theranostics"},{"key":"10.1016\/j.yexcr.2026.115145_bib100","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/1440-1681.13748","article-title":"FTO demethylates m6A modifications in CDKAL1 mRNA and promotes gastric cancer chemoresistance by altering mitochondrial dynamics","volume":"50","author":"Liu","year":"2023","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.yexcr.2026.115145_bib101","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/s41420-023-01505-y","article-title":"The role of m(6)A demethylase FTO in chemotherapy resistance mediating acute myeloid leukemia relapse","volume":"9","author":"Zhang","year":"2023","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.yexcr.2026.115145_bib110","article-title":"Fat mass and obesity-associated protein contributes to tumorigenesis and drug resistance of diffuse large B-Cell lymphoma by suppressing N6-Methyladenosine methylation of myc","author":"Lu","year":"2026","journal-title":"Kaohsiung J. Med. Sci."},{"key":"10.1016\/j.yexcr.2026.115145_bib111","doi-asserted-by":"crossref","DOI":"10.1016\/j.abb.2024.110072","article-title":"Fat mass and obesity-associated protein (FTO)-induced upregulation of flotillin-2 (FLOT2) contributes to cancer aggressiveness in diffuse large B-cell lymphoma (DLBCL) via activating the PI3K\/Akt\/mTOR signal pathway","volume":"758","author":"Zhang","year":"2024","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.yexcr.2026.115145_bib113","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1384141","article-title":"FTO diversely influences sensitivity of neuroblastoma cells to various chemotherapeutic drugs","volume":"15","author":"Lin","year":"2024","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.yexcr.2026.115145_bib112","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/s00432-023-05541-0","article-title":"The m(6)A demethylase FTO targets POLQ to promote ccRCC cell proliferation and genome stability maintenance","volume":"150","author":"He","year":"2024","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.yexcr.2026.115145_bib119","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.ccell.2019.03.006","article-title":"Small-molecule targeting of oncogenic FTO demethylase in acute myeloid leukemia","volume":"35","author":"Huang","year":"2019","journal-title":"Cancer Cell"},{"key":"10.1016\/j.yexcr.2026.115145_bib120","doi-asserted-by":"crossref","first-page":"2742","DOI":"10.1021\/acs.jmedchem.4c02076","article-title":"Discovery of novel RNA demethylase FTO inhibitors featuring an acylhydrazone scaffold with potent antileukemia activity","volume":"68","author":"Liang","year":"2025","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.yexcr.2026.115145_bib121","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.ccell.2020.04.017","article-title":"Targeting FTO suppresses cancer stem cell maintenance and immune evasion","volume":"38","author":"Su","year":"2020","journal-title":"Cancer Cell"},{"key":"10.1016\/j.yexcr.2026.115145_bib122","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2025.117444","article-title":"Development of 3-arylaminothiophenic-2-carboxylic acid derivatives as new FTO inhibitors showing potent antileukemia activities","volume":"289","author":"Zhang","year":"2025","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.yexcr.2026.115145_bib125","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2024.116375","article-title":"Targeting FTO suppresses hepatocellular carcinoma by inhibiting ERBB3 and TUBB4A expression","volume":"226","author":"Jiang","year":"2024","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.yexcr.2026.115145_bib126","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.freeradbiomed.2025.07.004","article-title":"FTO inhibition represses B-cell acute lymphoblastic leukemia progression by inducing nucleolar stress and mitochondrial dysfunction","volume":"238","author":"Li","year":"2025","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.yexcr.2026.115145_bib127","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14235919","article-title":"Targeting FTO suppresses pancreatic carcinogenesis via regulating stem cell maintenance and EMT pathway","volume":"14","author":"Garg","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.yexcr.2026.115145_bib128","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1038\/s41388-026-03754-4","article-title":"Targeting FTO shows therapeutic potential in esophageal squamous cell carcinoma by modulating microRNA biogenesis","volume":"45","author":"Zhou","year":"2026","journal-title":"Oncogene"},{"key":"10.1016\/j.yexcr.2026.115145_bib129","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-026-08647-8","article-title":"RNA N6-methyladenosine (m6A) regulates cell cycle progression in diffuse midline glioma (DMG) and confers sensitivity to FTO inhibition","volume":"17","author":"Ross","year":"2026","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.yexcr.2026.115145_bib123","doi-asserted-by":"crossref","first-page":"eadv7648","DOI":"10.1126\/sciadv.adv7648","article-title":"FTO degrader impairs ribosome biogenesis and protein translation in acute myeloid leukemia","volume":"11","author":"Li","year":"2025","journal-title":"Sci. Adv."},{"key":"10.1016\/j.yexcr.2026.115145_bib124","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aau7116","article-title":"Identification of entacapone as a chemical inhibitor of FTO mediating metabolic regulation through FOXO1","volume":"11","author":"Peng","year":"2019","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.yexcr.2026.115145_bib131","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.70090","article-title":"Homoharringtonine promotes FTO degradation to suppress LILRB4-Mediated immune evasion in acute monocytic leukaemia","volume":"59","author":"Huang","year":"2026","journal-title":"Cell Prolif."},{"key":"10.1016\/j.yexcr.2026.115145_bib135","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20200842","article-title":"Omeprazole improves chemosensitivity of gastric cancer cells by m6A demethylase FTO-mediated activation of mTORC1 and DDIT3 up-regulation","volume":"41","author":"Feng","year":"2021","journal-title":"Biosci. Rep."},{"key":"10.1016\/j.yexcr.2026.115145_bib136","article-title":"Meclofenamic acid restores gefinitib sensitivity by downregulating breast cancer resistance protein and multidrug resistance protein 7 via FTO\/m6A-Demethylation\/c-Myc in non-small cell lung cancer","volume":"12","author":"Chen","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.yexcr.2026.115145_bib132","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbamcr.2025.119969","article-title":"Baicalein disrupts TGF-\u03b2-induced EMT in pancreatic cancer by FTO-dependent m6A demethylation of ZEB1","volume":"1872","author":"Zhao","year":"2025","journal-title":"Biochim. Biophys. Acta Mol. Cell Res."},{"key":"10.1016\/j.yexcr.2026.115145_bib81","doi-asserted-by":"crossref","DOI":"10.1186\/s12575-026-00327-3","article-title":"Astragaloside IV suppresses gastric cancer by m6A-dependent FSP1 modulation and ferroptosis induction","volume":"28","author":"Yin","year":"2026","journal-title":"Biol. Proced. Online"},{"key":"10.1016\/j.yexcr.2026.115145_bib79","article-title":"Targeting the FTO-ACSL4 pathway: a novel mechanism for Sanguinarine Chloride-induced ferroptosis in endometrial cancer","volume":"14","author":"Li","year":"2026","journal-title":"Biomedicines"},{"key":"10.1016\/j.yexcr.2026.115145_bib133","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1097\/CAD.0000000000001608","article-title":"Rhein exerts anti-multidrug resistance in acute myeloid leukemia via targeting FTO to inhibit AKT\/mTOR","volume":"35","author":"Zhang","year":"2024","journal-title":"Anti Cancer Drugs"},{"key":"10.1016\/j.yexcr.2026.115145_bib134","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainres.2025.149889","article-title":"A novel derivative of rhein overcomes temozolomide resistance in glioblastoma by regulating SOX9 through m(6)A methylation","volume":"1866","author":"Cheng","year":"2025","journal-title":"Brain Res."},{"key":"10.1016\/j.yexcr.2026.115145_bib138","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1136\/gutjnl-2024-331903","article-title":"Targeting the oncogenic m6A demethylase FTO suppresses tumourigenesis and potentiates immune response in hepatocellular carcinoma","volume":"74","author":"Chen","year":"2024","journal-title":"Gut"},{"key":"10.1016\/j.yexcr.2026.115145_bib139","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.184968","article-title":"FTO inhibition enhances the therapeutic index of radiation therapy in head and neck cancer","volume":"10","author":"Ji","year":"2025","journal-title":"JCI Insight"},{"key":"10.1016\/j.yexcr.2026.115145_bib140","doi-asserted-by":"crossref","first-page":"S370","DOI":"10.1016\/j.ygyno.2026.01.641","article-title":"Inhibition of the m6A RNA demethylase FTO radiosensitizes cervical cancer by enhancing DNA damage: preclinical data on an emerging novel cancer therapeutic target","volume":"208","author":"Adams","year":"2026","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.yexcr.2026.115145_bib141","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2025.111782","article-title":"The m6A RNA demethylase FTO promotes radioresistance and stemness maintenance of glioma stem cells","volume":"132","author":"Zhang","year":"2025","journal-title":"Cell. Signal."},{"key":"10.1016\/j.yexcr.2026.115145_bib142","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1002\/mc.22782","article-title":"FTO regulates the chemo-radiotherapy resistance of cervical squamous cell carcinoma (CSCC) by targeting \u03b2-catenin through mRNA demethylation","volume":"57","author":"Zhou","year":"2018","journal-title":"Mol. Carcinog."},{"key":"10.1016\/j.yexcr.2026.115145_bib80","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2022.101576","article-title":"m6A demethylase FTO renders radioresistance of nasopharyngeal carcinoma via promoting OTUB1-mediated anti-ferroptosis","volume":"27","author":"Huang","year":"2023","journal-title":"Transl. Oncol."},{"key":"10.1016\/j.yexcr.2026.115145_bib143","doi-asserted-by":"crossref","first-page":"3945","DOI":"10.1158\/0008-5472.CAN-20-0132","article-title":"FTO inhibition enhances the antitumor effect of temozolomide by targeting MYC-miR-155\/23a Cluster-MXI1 feedback circuit in glioma","volume":"80","author":"Xiao","year":"2020","journal-title":"Cancer Res."},{"key":"10.1016\/j.yexcr.2026.115145_bib171","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2025.116841","article-title":"Phosducin inhibits the cell proliferation and promotes the antitumor effect of temozolomide in glioma","volume":"235","author":"Jiang","year":"2025","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.yexcr.2026.115145_bib144","doi-asserted-by":"crossref","first-page":"eabf6045","DOI":"10.1126\/scitranslmed.abf6045","article-title":"Aberrant activation of m6A demethylase FTO renders HIF2\u03b1(low\/-) clear cell renal cell carcinoma sensitive to BRD9 inhibitors","volume":"13","author":"Zhang","year":"2021","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.yexcr.2026.115145_bib145","doi-asserted-by":"crossref","first-page":"7063","DOI":"10.7150\/ijbs.117999","article-title":"Combination of FTO and BTK inhibitors synergistically suppresses the malignancy of breast cancer cells","volume":"21","author":"Saad","year":"2025","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.yexcr.2026.115145_bib146","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/s43018-021-00223-7","article-title":"Downregulation of the FTO m(6)A RNA demethylase promotes EMT-mediated progression of epithelial tumors and sensitivity to Wnt inhibitors","volume":"2","author":"Jeschke","year":"2021","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.yexcr.2026.115145_bib147","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s12951-025-03872-3","article-title":"Peptide-modified phase-transition nanoparticles co-deliver FTO siRNA and Ce6 for sonodynamic metabolism-immunotherapy of melanoma","volume":"24","author":"Li","year":"2025","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.yexcr.2026.115145_bib86","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2025.123168","article-title":"A novel FTO-targeting nanodrug induces disulfidptosis and ameliorates the suppressive tumor immune environment to treat uveal melanoma","volume":"319","author":"Tian","year":"2025","journal-title":"Biomaterials"},{"key":"10.1016\/j.yexcr.2026.115145_bib148","doi-asserted-by":"crossref","DOI":"10.1002\/sstr.202400100","article-title":"Multifunctional nanodrug\u2010mediated immunotherapy in microsatellite stable colorectal cancer via promoting m6A modification and M1\u2010Like tumor\u2010associated macrophages polarization","volume":"5","author":"Li","year":"2024","journal-title":"Small Struct."},{"key":"10.1016\/j.yexcr.2026.115145_bib149","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202106558","article-title":"Glutathione-bioimprinted nanoparticles targeting of N6-methyladenosine FTO demethylase as a strategy against leukemic stem cells","volume":"18","author":"Cao","year":"2022","journal-title":"Small"},{"key":"10.1016\/j.yexcr.2026.115145_bib57","first-page":"3376","article-title":"Decreased nuclear expression of FTO in human primary hepatocellular carcinoma is associated with poor prognosis","volume":"12","author":"Zhao","year":"2019","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"10.1016\/j.yexcr.2026.115145_bib172","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1038\/s41467-021-21758-4","article-title":"FTO-mediated cytoplasmic m6Am demethylation adjusts stem-like properties in colorectal cancer cell","volume":"12","author":"Relier","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.yexcr.2026.115145_bib59","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.4149\/neo_2022_220714N714","article-title":"PRKAA1, stabilized by FTO in an m6A-YTHDF2-dependent manner, promotes cell proliferation and glycolysis of gastric cancer by regulating the redox balance","volume":"69","author":"Zhang","year":"2022","journal-title":"Neoplasma"},{"key":"10.1016\/j.yexcr.2026.115145_bib90","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2026.1713267","article-title":"Integrative single-cell, spatial, and bulk transcriptomics reveal an FMR1-FTO axis linked to the immune-excluded phenotype in gastric cancer","volume":"17","author":"Mao","year":"2026","journal-title":"Front. Immunol."},{"key":"10.1016\/j.yexcr.2026.115145_bib65","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1038\/s41419-025-08049-2","article-title":"m(6)A demethylase FTO drives pancreatic ductal adenocarcinoma tumorigenesis and metastasis through remodeling PFKM mediated glycolysis","volume":"16","author":"Tan","year":"2025","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.yexcr.2026.115145_bib68","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/s00432-024-06073-x","article-title":"FTO effects the proliferation, invasion, and glycolytic metabolism of colon cancer by regulating PKM2","volume":"151","author":"Zhang","year":"2025","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.yexcr.2026.115145_bib169","doi-asserted-by":"crossref","DOI":"10.1016\/j.pupt.2023.102227","article-title":"Serum exosomal m6A demethylase FTO promotes gefitinib resistance in non-small cell lung cancer by up-regulating FLRT3, PTGIS and SIRP\u03b1 expression","volume":"82","author":"Wang","year":"2023","journal-title":"Pulm. Pharmacol. Ther."},{"key":"10.1016\/j.yexcr.2026.115145_bib32","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1038\/nmeth.3453","article-title":"Single-nucleotide-resolution mapping of m6A and m6Am throughout the transcriptome","volume":"12","author":"Linder","year":"2015","journal-title":"Nat. Methods"},{"key":"10.1016\/j.yexcr.2026.115145_bib33","doi-asserted-by":"crossref","first-page":"15995","DOI":"10.1002\/anie.201807942","article-title":"An Elongation- and ligation-based qPCR amplification method for the radiolabeling-free detection of locus-specific N(6) -Methyladenosine modification","volume":"57","author":"Xiao","year":"2018","journal-title":"Angew Chem. Int. Ed. Engl."},{"key":"10.1016\/j.yexcr.2026.115145_bib34","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/s41587-022-01487-9","article-title":"Absolute quantification of single-base m(6)A methylation in the mammalian transcriptome using GLORI","volume":"41","author":"Liu","year":"2023","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.yexcr.2026.115145_bib55","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1038\/s41467-021-21758-4","article-title":"FTO-mediated cytoplasmic m(6)A(m) demethylation adjusts stem-like properties in colorectal cancer cell","volume":"12","author":"Relier","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.yexcr.2026.115145_bib56","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.70392","article-title":"FTO-mediated m(6)A demethylation regulates IGFBP3 expression and AKT activation through IMP3-dependent P-body re-localisation in lung cancer","volume":"15","author":"Wang","year":"2025","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.yexcr.2026.115145_bib58","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/s42003-024-05880-9","article-title":"KCTD15 acts as an anti-tumor factor in colorectal cancer cells downstream of the demethylase FTO and the m6A reader YTHDF2","volume":"7","author":"Zhang","year":"2024","journal-title":"Commun. Biol."},{"key":"10.1016\/j.yexcr.2026.115145_bib60","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s13005-025-00547-0","article-title":"FTO enhances OSCC progression via m6A-dependent stabilization of PKM2 mRNA through YTHDF2 modulation","volume":"21","author":"Wu","year":"2025","journal-title":"Head Face Med."},{"key":"10.1016\/j.yexcr.2026.115145_bib61","doi-asserted-by":"crossref","DOI":"10.1016\/j.abb.2025.110438","article-title":"TNF-\u03b1 inhibites non-small cell lung cancer cells proliferation by targeting THRIL in an FTO-YTHDF2-dependent manner","volume":"770","author":"Dong","year":"2025","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.yexcr.2026.115145_bib62","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1186\/s13578-023-01100-9","article-title":"Down-regulated FTO and ALKBH5 co-operatively activates FOXO signaling through m6A methylation modification in HK2 mRNA mediated by IGF2BP2 to enhance glycolysis in colorectal cancer","volume":"13","author":"Ye","year":"2023","journal-title":"Cell Biosci."},{"key":"10.1016\/j.yexcr.2026.115145_bib63","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1007\/s12672-024-01051-8","article-title":"GAS5 regulated by FTO-mediated m6A modification suppresses cell proliferation via the IGF2BP2\/QKI axis in breast cancer","volume":"15","author":"Yan","year":"2024","journal-title":"Discov. Oncol."},{"key":"10.1016\/j.yexcr.2026.115145_bib64","article-title":"FTO regulates centrosome function and mitotic fidelity in cancers with chromosome instability (CIN)","author":"Cohen-Attali","year":"2026","journal-title":"bioRxiv"},{"key":"10.1016\/j.yexcr.2026.115145_bib66","doi-asserted-by":"crossref","first-page":"eadq3052","DOI":"10.1126\/sciadv.adq3052","article-title":"FTO regulates ELK3-mediated metabolic rewiring and represents a unique therapeutic target in T cell leukemia","volume":"11","author":"Huang","year":"2025","journal-title":"Sci. Adv."},{"key":"10.1016\/j.yexcr.2026.115145_bib70","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.7150\/ijbs.103428","article-title":"FTO-induced APOE promotes the malignant progression of pancreatic neuroendocrine neoplasms through FASN-mediated lipid metabolism","volume":"21","author":"Chen","year":"2025","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.yexcr.2026.115145_bib71","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s13578-022-00798-3","article-title":"m6A demethylase FTO promotes tumor progression via regulation of lipid metabolism in esophageal cancer","volume":"12","author":"Duan","year":"2022","journal-title":"Cell Biosci."},{"key":"10.1016\/j.yexcr.2026.115145_bib72","article-title":"The FTO-regulated circNFATC3\/miR-23b-3p axis promotes RAI14-mediated gastric cancer progression via lipid metabolic reprogramming","author":"Yan","year":"2026","journal-title":"Research Square"},{"key":"10.1016\/j.yexcr.2026.115145_bib73","doi-asserted-by":"crossref","first-page":"4685","DOI":"10.3892\/ol.2017.6038","article-title":"The lipid metabolism gene FTO influences breast cancer cell energy metabolism via the PI3K\/AKT signaling pathway","volume":"13","author":"Liu","year":"2017","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.yexcr.2026.115145_bib74","doi-asserted-by":"crossref","first-page":"eadv2417","DOI":"10.1126\/sciadv.adv2417","article-title":"The RNA demethylase FTO promotes glutamine metabolism in clear cell renal cell carcinoma through the regulation of SLC1A5","volume":"11","author":"Zhao","year":"2025","journal-title":"Sci. Adv."},{"key":"10.1016\/j.yexcr.2026.115145_bib75","doi-asserted-by":"crossref","DOI":"10.20892\/j.issn.2095-3941.2025.0444","article-title":"Mitochondrial uncoupling inhibits serine catabolism via FTO activation in metastatic breast cancer","author":"Jin","year":"2026","journal-title":"Cancer Biol. Med."},{"key":"10.1016\/j.yexcr.2026.115145_bib76","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0159072","article-title":"Important role of FTO in the survival of rare panresistant triple-negative inflammatory breast cancer cells facing a severe metabolic challenge","volume":"11","author":"Singh","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.yexcr.2026.115145_bib77","article-title":"FTO sensitizes oral squamous cell carcinoma to ferroptosis via suppressing ACSL3 and GPX4","volume":"24","author":"Wang","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.yexcr.2026.115145_bib78","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.857765","article-title":"FTO prevents thyroid cancer progression by SLC7A11 m6A methylation in a ferroptosis-dependent manner","volume":"13","author":"Ji","year":"2022","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.yexcr.2026.115145_bib82","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1007\/s00018-025-05855-x","article-title":"Mechanism of LncRNA NORAD regulating ferroptosis in endometrial cancer cells by modifying GPX4 through FTO-mediated m6A methylation","volume":"82","author":"Ke","year":"2025","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.yexcr.2026.115145_bib83","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1186\/s12967-026-07715-z","article-title":"Long noncoding RNA PCAT7 confers radioresistance of esophageal squamous cell carcinoma by promoting GCLM-mediated anti-ferroptosis","volume":"24","author":"Hao","year":"2026","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.yexcr.2026.115145_bib84","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2024.103382","article-title":"FMRP protects breast cancer cells from ferroptosis by promoting SLC7A11 alternative splicing through interacting with hnRNPM","volume":"77","author":"Wang","year":"2024","journal-title":"Redox Biol."},{"key":"10.1016\/j.yexcr.2026.115145_bib87","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.jare.2024.12.026","article-title":"FTO activates PD-L1 promotes immunosuppression in breast cancer via the m6A\/YTHDF3\/PDK1 axis under hypoxic conditions","volume":"76","author":"Wang","year":"2025","journal-title":"J. Adv. Res."},{"key":"10.1016\/j.yexcr.2026.115145_bib88","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.bbrc.2020.06.153","article-title":"RNA N6-methyladenosine demethylase FTO regulates PD-L1 expression in colon cancer cells","volume":"530","author":"Tsuruta","year":"2020","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.yexcr.2026.115145_bib89","article-title":"Comprehensive analysis of PD-L1 expression, immune infiltrates, and m6A RNA methylation regulators in esophageal squamous cell carcinoma","volume":"12","author":"Guo","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.yexcr.2026.115145_bib91","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtcvs.2026.03.436","article-title":"FTO m6A methylation orchestrates the inhibition of CD8+ T cell in tumor microenvironment of esophageal squamous cell carcinoma","volume":"171","author":"Li","year":"2026","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"10.1016\/j.yexcr.2026.115145_bib92","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.216911","article-title":"FTO elicits tumor neovascularization in cancer-associated fibroblasts through eliminating m(6)A modifications of multiple pro-angiogenic factors","volume":"592","author":"Liao","year":"2024","journal-title":"Cancer Lett."},{"key":"10.1016\/j.yexcr.2026.115145_bib114","article-title":"The tumor-to-endothelial transfer of FTO promotes vascular remodeling and metastasis in nasopharyngeal carcinoma","volume":"13","author":"Wu","year":"2026","journal-title":"Adv. Sci. (Weinh.)"},{"key":"10.1016\/j.yexcr.2026.115145_bib115","doi-asserted-by":"crossref","DOI":"10.1016\/j.envres.2023.117783","article-title":"Exosome-shuttled FTO from BM-MSCs contributes to cancer malignancy and chemoresistance in acute myeloid leukemia by inducing m6A-demethylation: a nano-based investigation","volume":"244","author":"Kou","year":"2024","journal-title":"Environ. Res."},{"key":"10.1016\/j.yexcr.2026.115145_bib116","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1158\/1541-7786.MCR-20-0541","article-title":"Exosomal delivery of FTO confers gefitinib resistance to recipient cells through ABCC10 regulation in an m6A-dependent manner","volume":"19","author":"Xiao","year":"2021","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.yexcr.2026.115145_bib117","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1038\/s41419-022-05317-3","article-title":"Senescent neutrophils-derived exosomal piRNA-17560 promotes chemoresistance and EMT of breast cancer via FTO-mediated m6A demethylation","volume":"13","author":"Ou","year":"2022","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.yexcr.2026.115145_bib118","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1186\/s12903-025-06082-3","article-title":"Cancer-associated fibroblasts-derived exosomal piR-35462 promotes the progression of oral squamous cell carcinoma via FTO\/Twist1 pathway","volume":"25","author":"Ye","year":"2025","journal-title":"BMC Oral Health"},{"key":"10.1016\/j.yexcr.2026.115145_bib130","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2024.103067","article-title":"FTO ameliorates doxorubicin-induced cardiotoxicity by inhibiting ferroptosis via P53-P21\/Nrf2 activation in a HuR-dependent m6A manner","volume":"70","author":"Yang","year":"2024","journal-title":"Redox Biol."},{"key":"10.1016\/j.yexcr.2026.115145_bib137","doi-asserted-by":"crossref","first-page":"2782","DOI":"10.1038\/s41467-019-10669-0","article-title":"m(6)A mRNA demethylase FTO regulates melanoma tumorigenicity and response to anti-PD-1 blockade","volume":"10","author":"Yang","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.yexcr.2026.115145_bib150","doi-asserted-by":"crossref","first-page":"5323","DOI":"10.1080\/21655979.2021.1964893","article-title":"The tumor-suppressive effects of alpha-ketoglutarate-dependent dioxygenase FTO via N6-methyladenosine RNA methylation on bladder cancer patients","volume":"12","author":"Yi","year":"2021","journal-title":"Bioengineered"},{"key":"10.1016\/j.yexcr.2026.115145_bib151","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbamcr.2026.120147","article-title":"FTO-mediated m6A demethylation inhibits bladder cancer progression via decreasing EMG1 and reducing ribosome biosynthesis","volume":"1873","author":"Yao","year":"2026","journal-title":"Biochim. Biophys. Acta Mol. Cell Res."},{"key":"10.1016\/j.yexcr.2026.115145_bib152","doi-asserted-by":"crossref","DOI":"10.1016\/j.abb.2023.109604","article-title":"FTO-stabilized miR-139-5p targets ZNF217 to suppress prostate cancer cell malignancies by inactivating the PI3K\/Akt\/mTOR signal pathway","volume":"741","author":"Azhati","year":"2023","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.yexcr.2026.115145_bib153","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2024.110505","article-title":"DNA damage-mediated FTO downregulation promotes CRPC progression by inhibiting FOXO3a via an m(6)A-dependent mechanism","volume":"27","author":"Xu","year":"2024","journal-title":"iScience"},{"key":"10.1016\/j.yexcr.2026.115145_bib154","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1038\/s41420-024-02060-w","article-title":"ZFHX3 acts as a tumor suppressor in prostate cancer by targeting FTO-mediated m(6)A demethylation","volume":"10","author":"Hu","year":"2024","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.yexcr.2026.115145_bib155","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/s41420-022-01003-7","article-title":"N6-methyladenosine demethylase FTO suppressed prostate cancer progression by maintaining CLIC4 mRNA stability","volume":"8","author":"Zou","year":"2022","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.yexcr.2026.115145_bib156","doi-asserted-by":"crossref","first-page":"426","DOI":"10.55730\/1300-0152.2629","article-title":"Demethylase FTO inhibits the development of prostate cancer by upregulating EGR2 expression in an m6A manner","volume":"46","author":"Wang","year":"2022","journal-title":"Turk. J. Biol."},{"key":"10.1016\/j.yexcr.2026.115145_bib157","doi-asserted-by":"crossref","DOI":"10.1155\/ijog\/4209006","article-title":"FTO acts as a suppressor gene to inhibit the translation of KDM5A mRNA by demethylating m6A modifications in lung adenocarcinoma","volume":"2026","author":"Zhao","year":"2026","journal-title":"International Journal of Genomics"},{"key":"10.1016\/j.yexcr.2026.115145_bib158","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s13046-022-02254-z","article-title":"FTO suppresses glycolysis and growth of papillary thyroid cancer via decreasing stability of APOE mRNA in an N6-methyladenosine-dependent manner","volume":"41","author":"Huang","year":"2022","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.yexcr.2026.115145_bib159","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s13578-025-01395-w","article-title":"FTO downregulation-mediated m6A modification resulting in enhanced hepatocellular carcinoma invasion","volume":"15","author":"Zhou","year":"2025","journal-title":"Cell Biosci."},{"key":"10.1016\/j.yexcr.2026.115145_bib160","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2025.1667990","article-title":"The m6A demethylase FTO suppresses glioma proliferation by regulating the EREG\/PI3K\/Akt signaling pathway","volume":"13","author":"Zhai","year":"2025","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.yexcr.2026.115145_bib161","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s11064-025-04334-w","article-title":"FTO suppresses proliferation and induces apoptosis of T98G glioblastoma cells via N6-methyladenosine modification of GSTO1","volume":"50","author":"Dong","year":"2025","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.yexcr.2026.115145_bib162","doi-asserted-by":"crossref","first-page":"114","DOI":"10.3724\/abbs.2023267","article-title":"Demethylase FTO inhibits the occurrence and development of triple-negative breast cancer by blocking m (6)A-dependent miR-17-5p maturation-induced ZBTB4 depletion","volume":"56","author":"Ni","year":"2024","journal-title":"Acta Biochim. Biophys. Sin."},{"key":"10.1016\/j.yexcr.2026.115145_bib163","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.112142","article-title":"Unveiling the role of FTO polymorphisms in predicting response to immune checkpoint inhibitors: a retrospective study","volume":"133","author":"Liu","year":"2024","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.yexcr.2026.115145_bib164","article-title":"Machine learning-based comprehensive analysis of m6A RNA methylation regulators in colorectal cancer: implications for prognosis, immune microenvironment, and immunotherapy response","volume":"250","author":"Kong","year":"2025","journal-title":"Exp. Biol. Med."},{"key":"10.1016\/j.yexcr.2026.115145_bib165","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-025-22002-5","article-title":"Identification of a m6A-immune-related risk model for predicting prognosis, immune microenvironment, and drug responses in acute myeloid leukemia","volume":"15","author":"Bai","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.yexcr.2026.115145_bib166","doi-asserted-by":"crossref","DOI":"10.1007\/s00277-026-06940-2","article-title":"FTO-CHRM3 axis regulates multiple myeloma progression: a machine learning-based identification","volume":"105","author":"Lu","year":"2026","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.yexcr.2026.115145_bib167","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1038\/s41416-021-01581-w","article-title":"Novel evidence for m(6)A methylation regulators as prognostic biomarkers and FTO as a potential therapeutic target in gastric cancer","volume":"126","author":"Shimura","year":"2022","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.yexcr.2026.115145_bib168","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines14030723","article-title":"Pan-cancer analysis identifies SNORA12 as a prognostic biomarker and demonstrates its role in upregulating TIGIT in osteosarcoma","volume":"14","author":"He","year":"2026","journal-title":"Biomedicines"},{"key":"10.1016\/j.yexcr.2026.115145_bib170","doi-asserted-by":"crossref","DOI":"10.1002\/kjm2.70158","article-title":"Fat mass and obesity-associated protein contributes to tumorigenesis and drug resistance of diffuse large B-Cell lymphoma by suppressing N6-Methyladenosine methylation of myc","volume":"42","author":"Lu","year":"2026","journal-title":"Kaohsiung J. Med. Sci."}],"container-title":["Experimental Cell Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014482726002624?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014482726002624?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T16:08:24Z","timestamp":1788538104000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014482726002624"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":172,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S0014482726002624"],"URL":"https:\/\/doi.org\/10.1016\/j.yexcr.2026.115145","relation":{},"ISSN":["0014-4827"],"issn-type":[{"value":"0014-4827","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"From contested target to context-aware node: A three-layer regulatory code for interpreting FTO's oncogene\u2013tumor suppressor paradox in cancer","name":"articletitle","label":"Article Title"},{"value":"Experimental Cell Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yexcr.2026.115145","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"115145"}}